Illuccix has gained significant market share due to changes in clinical practice and successful distribution. The company requires minimal capital and is expected to generate very high returns as it ...

BBC presenter Nick Owen says cancer diagnosis was ‘worst day of my life’ - Veteran presenter called the response he has ...

Ethakota, J. , Singh, B. , Bai, S. , Tareen, H. , Kumar, D. and Malik, D. (2025) The Role of Artificial Intelligence in ...

Bayer will present new data from the ARANOTE trial evaluating ultra-low prostate-specific antigen responses with NUBEQA ® ...

Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection) has been granted marketing ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

Cancer vaccines have been a tantalizing idea for decades, but the vast complexity of the human immune system has posed significant challenges. Now, technological advances like rapid DNA sequencing ...

male breast cancer, and melanoma." In December of last year, Knowles faced a new scare when his PSA (Prostate-Specific Antigen) levels were higher than normal. While he was fortunate to receive ...

U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “the world’s leading pan-isotype cancer antibody ... the folate receptor alpha antigen. While researchers ...

Nigeria faces a significant challenge with cancer, as it has one of the highest cancer rates in Africa, with a high mortality rate of about 74.6 per 100,000 people annually. This alarming statistic ...